Published in Emerg Infect Dis on March 01, 2004
Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis (2006) 2.12
Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev (2011) 1.66
Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem. PLoS One (2015) 1.59
Impact of statewide program to promote appropriate antimicrobial drug use. Emerg Infect Dis (2005) 1.35
Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis (2005) 1.27
High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol (2012) 1.15
Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections. Antimicrob Agents Chemother (2015) 1.10
The appropriateness of prescribing antibiotics in the community in Europe: study design. BMC Infect Dis (2011) 1.08
Socioeconomic determinants of outpatient antibiotic use in Europe. Int J Public Health (2010) 1.08
Development and assessment of a questionnaire for a descriptive cross-sectional study concerning parents' knowledge, attitudes and practises in antibiotic use in Greece. BMC Infect Dis (2009) 1.06
Nonprescribed antimicrobial drugs in Latino community, South Carolina. Emerg Infect Dis (2005) 1.05
Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother (2006) 1.04
Ambulatory antibiotic prescribing for acute bronchitis and cough and hospital admissions for respiratory infections: time trends analysis. J R Soc Med (2006) 1.03
Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. PLoS One (2010) 1.03
Defining pathogenic bacterial species in the genomic era. Front Microbiol (2011) 1.02
Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at University of Gondar Teaching Hospital, Northwest Ethiopia. BMC Res Notes (2012) 1.01
Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev (2013) 1.01
CEM-101 activity against Gram-positive organisms. Antimicrob Agents Chemother (2010) 1.00
Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand. Bull World Health Organ (2012) 0.97
Properties of novel international drug-resistant pneumococcal clones identified in day-care centers of Lisbon, Portugal. J Clin Microbiol (2005) 0.97
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection (2016) 0.97
Antibiotic-resistant invasive pneumococcal clones in Italy. J Clin Microbiol (2006) 0.96
Assessing the impact of national antibiotic campaigns in Europe. Eur J Health Econ (2012) 0.95
Expansion and evolution of the Streptococcus pneumoniae Spain9V-ST156 clonal complex in Poland. Antimicrob Agents Chemother (2010) 0.94
Long-term effects of an educational seminar on antibiotic prescribing by GPs: a randomised controlled trial. Br J Gen Pract (2013) 0.94
Infectious disease management in primary care: perceptions of GPs. BMC Fam Pract (2011) 0.93
Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. J Clin Microbiol (2005) 0.90
Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting. J Clin Microbiol (2005) 0.89
Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria. Antimicrob Agents Chemother (2011) 0.89
Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center. Int J Circumpolar Health (2013) 0.87
Phenotypic and molecular analysis of penicillin-nonsusceptible Streptococcus pneumoniae isolates in Poland. Antimicrob Agents Chemother (2006) 0.86
Antimicrobial use in a country with insufficient enforcement of pharmaceutical regulations: A survey of consumption and retail sales in Ulaanbaatar, Mongolia. South Med Rev (2010) 0.86
Access, excess, and ethics--towards a sustainable distribution model for antibiotics. Ups J Med Sci (2014) 0.85
Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. BMC Infect Dis (2016) 0.84
The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity? J Med Internet Res (2015) 0.84
Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era. Arch Intern Med (2010) 0.84
Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community. BMC Fam Pract (2014) 0.83
Surveillance of antimicrobial resistance among clinical isolates recovered from a tertiary care hospital in Al Qassim, Saudi Arabia. Int J Health Sci (Qassim) (2014) 0.82
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis (2012) 0.82
Infection biomarkers in primary care patients with acute respiratory tract infections-comparison of Procalcitonin and C-reactive protein. BMC Pulm Med (2016) 0.81
Antibiotic resistance in the wild: an eco-evolutionary perspective. Philos Trans R Soc Lond B Biol Sci (2017) 0.80
Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae isolates from elderly patients with pneumonia and acute exacerbation of chronic obstructive pulmonary disease. Antimicrob Agents Chemother (2011) 0.80
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials. Antibiotics (Basel) (2016) 0.79
Comparative genomics evidence that only protein toxins are tagging bad bugs. Front Cell Infect Microbiol (2011) 0.79
Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections. Antibiotics (Basel) (2013) 0.78
Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India. Indian J Pharmacol (2015) 0.78
UniDrug-target: a computational tool to identify unique drug targets in pathogenic bacteria. PLoS One (2012) 0.78
Antibiotic use and resistance: a cross-sectional study exploring knowledge and attitudes among school and institution personnel in Tbilisi, Republic of Georgia. BMC Res Notes (2015) 0.77
Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis. Sci Rep (2015) 0.77
Physicians' attitudes and knowledge concerning antibiotic prescription and resistance: questionnaire development and reliability. BMC Infect Dis (2016) 0.77
Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial. Eur J Clin Microbiol Infect Dis (2008) 0.77
Senescence and antibiotic resistance in an age-structured population model. J Math Biol (2009) 0.76
Pre and post-interventional pattern of self medication in three common illnesses in staff of a tertiary hospital. Indian J Pharmacol (2011) 0.75
Save Antibiotics: a call for action of the World Alliance Against Antibiotic Resistance (WAAAR). BMC Infect Dis (2014) 0.75
Understanding Antibiotic Use in Minya District, Egypt: Physician and Pharmacist Prescribing and the Factors Influencing Their Practices. Antibiotics (Basel) (2014) 0.75
Antibiotic Resistance Patterns of Common Gram-negative Uropathogens in St. Paul's Hospital Millennium Medical College. Ethiop J Health Sci (2016) 0.75
Genome Analysis of Streptococcus pyogenes Associated with Pharyngitis and Skin Infections. PLoS One (2016) 0.75
Antibiotic use and clinical outcomes in the acute setting under management by an infectious diseases acute physician versus other clinical teams: a cohort study. BMJ Open (2016) 0.75
Methicillin-Resistant Staphylococcus aureus Nasal Colonization in Chinese Children: A Prevalence Meta-Analysis and Review of Influencing Factors. PLoS One (2016) 0.75
Bacterial profile of urinary tract infection and antimicrobial susceptibility pattern among pregnant women attending at Antenatal Clinic in Dil Chora Referral Hospital, Dire Dawa, Eastern Ethiopia. Ther Clin Risk Manag (2016) 0.75
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med (1997) 9.63
Variation in antibiotic use in the European Union. Lancet (2001) 6.02
A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis (2002) 4.61
Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis (1984) 4.42
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med (2003) 3.54
Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis (2003) 3.42
Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis (2002) 3.07
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother (2002) 2.30
The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother (2000) 2.27
Antibiotic use in the Australian community, 1990-1995. Med J Aust (1997) 2.02
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J Antimicrob Chemother (2000) 1.93
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis (2001) 1.92
Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother (2000) 1.87
Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis (2001) 1.62
Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis (2002) 1.57
Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis (2001) 1.49
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother (2000) 1.48
Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis (1998) 1.42
Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol (2002) 1.36
Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000. J Antimicrob Chemother (2002) 1.20
Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis (2001) 1.19
The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother (2000) 1.16
Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999). J Clin Microbiol (2000) 1.09
The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J Antimicrob Chemother (2001) 1.07
Resistance patterns of lower respiratory tract pathogens in Europe. Int J Antimicrob Agents (2000) 1.00
Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999. J Antimicrob Chemother (2001) 0.96
Macrolide-resistant group a streptococcus--now in the United States. N Engl J Med (2002) 0.92
Pneumococcal disease in Sweden: experiences and current situation. Am J Med (1999) 0.92
Antibiotic usage in Nordic countries. Int J Antimicrob Agents (2001) 0.91
Diversity of penicillin-nonsusceptible Streptococcus pneumoniae circulating in Iceland after the introduction of penicillin-resistant clone Spain(6B)-2. J Infect Dis (2002) 0.91
The prevalence of antibiotic resistance in bacterial respiratory pathogens from Norway is low. Clin Microbiol Infect (2001) 0.86
Assessment of the susceptibility of Streptococcus pneumoniae to cefaclor and loracarbef in 13 countries. J Chemother (2000) 0.80
Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia from 1997 to 2000. J Antimicrob Chemother (2002) 0.80
[Antibiotic use and bacterial resistance]. Ann Fr Anesth Reanim (2000) 0.80
Clostridium difficile infection in Europe: a hospital-based survey. Lancet (2011) 6.25
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol (2005) 5.86
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med (2006) 4.15
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis (2010) 3.65
Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother (2007) 3.44
Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis (2005) 3.18
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action. Antimicrob Resist Infect Control (2012) 3.02
Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med (2007) 2.88
Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis (2008) 2.79
Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? Clin Infect Dis (2004) 2.73
Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51
Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis (2009) 2.39
Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35
Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill (2016) 2.34
Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit Care Med (2004) 2.33
Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection. J Clin Microbiol (2005) 2.23
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Clin Infect Dis (2004) 2.22
Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis (2006) 2.12
Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J Antimicrob Chemother (2008) 2.11
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis (2007) 2.11
Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2007) 1.97
A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance. PLoS Med (2011) 1.88
Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates. J Clin Microbiol (2005) 1.88
Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother (2008) 1.87
Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment. Scand J Infect Dis (2002) 1.83
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care (2006) 1.70
Is self-medication with antibiotics in Europe driven by prescribed use? J Antimicrob Chemother (2006) 1.69
A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J Clin Microbiol (2004) 1.63
Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis (2011) 1.62
Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother (2008) 1.60
Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis (2004) 1.57
In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother (2006) 1.55
Is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol (2007) 1.51
Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance. J Antimicrob Chemother (2010) 1.51
Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis (2011) 1.50
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care (2005) 1.49
Comment on: withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health. Int J Antimicrob Agents (2007) 1.48
Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016. Euro Surveill (2016) 1.48
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill (2015) 1.45
Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now. Drug Resist Updat (2011) 1.40
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care (2007) 1.32
Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study. Pharmacoepidemiol Drug Saf (2007) 1.32
Self-medication with antibiotics in Europe: a case for action. Curr Drug Saf (2010) 1.31
Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital. Age Ageing (2005) 1.27
Should this event be notified to the World Health Organization? Reliability of the international health regulations notification assessment process. Bull World Health Organ (2011) 1.27
Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother (2009) 1.22
Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg Infect Dis (2008) 1.21
Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis (2009) 1.19
Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol (2006) 1.18
Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada. Can J Infect Dis (2004) 1.17
The environment and healthcare-acquired infections: why accurate reporting and evaluation of biological plausibility are important. Infect Control Hosp Epidemiol (2013) 1.15
Cost implications of successful hand hygiene promotion. Infect Control Hosp Epidemiol (2004) 1.15
Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist Updat (2011) 1.14
Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol (2012) 1.13
Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open (2013) 1.11
Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother (2011) 1.10
Priority actions to fight antibiotic resistance: results of an international meeting. Antimicrob Resist Infect Control (2012) 1.10
Severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2015) 1.09
Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier? Crit Care (2012) 1.08
Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. Swiss Med Wkly (2002) 1.08
Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect Control Hosp Epidemiol (2011) 1.06
Use of oligoarrays for characterization of community-onset methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 1.05
Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother (2006) 1.04
Danish integrated antimicrobial resistance monitoring and research program. Emerg Infect Dis (2007) 1.04
The rise of carbapenem resistance in Europe: just the tip of the iceberg? Antimicrob Resist Infect Control (2013) 1.04
Regional variations in community consumption of antibiotics in Hungary, 1996-2003. Br J Clin Pharmacol (2006) 1.03
Rapid identification of hospitalized patients at high risk for MRSA carriage. J Am Med Inform Assoc (2008) 1.02
Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis (2010) 1.02
Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis (2003) 1.02
Control of methicillin-resistant Staphylococcus aureus. Infect Dis Clin North Am (2011) 1.01
Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev (2013) 1.01
Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care (2014) 1.00
Rapid Staphylococcus aureus agr type determination by a novel multiplex real-time quantitative PCR assay. J Clin Microbiol (2006) 1.00
A comparison of antibiotic use in children between Canada and Denmark. Ann Pharmacother (2007) 1.00
Dissemination and sustainability of a hospital-wide hand hygiene program emphasizing positive reinforcement. Infect Control Hosp Epidemiol (2010) 0.99
High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2011) 0.99
Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit. J Infect (2009) 0.99
An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units. J Antimicrob Chemother (2014) 0.98
Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections. J Antimicrob Chemother (2011) 0.97
Preventing surgical site infections. Expert Rev Anti Infect Ther (2010) 0.97
Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2010) 0.97
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis (2012) 0.97
Patterns of antibiotic use in the community in Denmark. Scand J Infect Dis (2006) 0.96
The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol (2012) 0.96
Nursing resources: a major determinant of nosocomial infection? Curr Opin Infect Dis (2004) 0.95
Measuring antimicrobial use: the way forward. Clin Infect Dis (2007) 0.94
The PIRO concept: R is for response. Crit Care (2003) 0.94
At least it won't hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol (2011) 0.93
Daily chlorhexidine bathing and hospital-acquired infection. N Engl J Med (2013) 0.93
Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother (2013) 0.92
Rapid and high-throughput genotyping of Staphylococcus epidermidis isolates by automated multilocus variable-number of tandem repeats: a tool for real-time epidemiology. J Microbiol Methods (2008) 0.91
Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia. Am J Respir Crit Care Med (2002) 0.91
Complete Genome Sequences of Nitrofurantoin-Sensitive and -Resistant Escherichia coli ST540 and ST2747 Strains. Genome Announc (2014) 0.90
Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001. J Antimicrob Chemother (2004) 0.90
Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? Virulence (2013) 0.90
The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. J Hosp Infect (2007) 0.89
Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital. Curr Opin Infect Dis (2008) 0.89